Mice Expressing Mutant Myosin Heavy Chains Are a Model for Familial Hypertrophic Cardiomyopathy

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Molecular Medicine

• Publication date

  1996-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF03401640PMID 8898372PMCID PMC2230192
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transgenic animals as a tool for studying the effect of the c-myc proto-oncogene on cardiac development

  2004cited by this paper
• Contractile protein mutations and heart disease.

  1996cited by this paper
• A Mouse Model of Familial Hypertrophic Cardiomyopathy

  1996cited by this paper
• Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy

  1995cited by this paper
• Ventricular Expression of a MLC-2v-ras Fusion Gene Induces Cardiac Hypertrophy and Selective Diastolic Dysfunction in Transgenic Mice (*)

  1995cited by this paper
• Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.

  1995cited by this paper
• Cardiac myosin binding protein–C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy

  1995cited by this paper
• Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.

  1994cited by this paper
• Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction.

  1994cited by this paper
• Possible gene dose effect of a mutant cardiac beta-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy.

  1994cited by this paper
• Hypertrophic cardiomyopathy in pigs: quantitative pathologic features in 55 cases.

  1994cited by this paper
• Possible Gene Effect of a Mutant Cardiac β-Myosin Heavy Chain Gene on the Clinical Expression of Familial Hypertrophic Cardiomyopathy

  1994cited by this paper
• Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.

  1994cited by this paper
• Sarcomeric myosin heavy chain expressed in nonmuscle cells forms thick filaments in the presence of substoichiometric amounts of light chains.

  1993cited by this paper
• Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.

  1993cited by this paper
• Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy.

  1993cited by this paper
• Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice.

  1993cited by this paper
• Comparison of morphologic findings in spontaneously occurring hypertrophic cardiomyopathy in humans, cats and dogs.

  1993cited by this paper
• Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.

  1993cited by this paper
• Structure of the actin-myosin complex and its implications for muscle contraction.

  1993cited by this paper
• Idiopathic hypertrophic cardiomyopathy in identical twins. Morphological heterogeneity of the left ventricle.

  1992cited by this paper
• Characterization of the allelic differences in the mouse cardiac alpha-myosin heavy chain coding sequence.

  1992cited by this paper
• Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart.

  1991cited by this paper
• Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice.

  1991cited by this paper
• Skeletal actin mRNA increases in the human heart during ontogenic development and is the major isoform of control and failing adult hearts.

  1991cited by this paper
• Actin and myosin expression during development of cardiac muscle from cultured embryonal carcinoma cells.

  1990cited by this paper
• A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene.

  1990cited by this paper
• Developmental regulation of myosin gene expression in mouse cardiac muscle

  1990cited by this paper
• A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

  1990cited by this paper
• Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass.

  1990cited by this paper
• A molecular basis for familial hypertrophic cardiomyopathy: An αβ cardiac myosin heavy chain hybrid gene

  1990cited by this paper
• Complete nucleotide sequence of full length cDNA for rat alpha cardiac myosin heavy chain.

  1989cited by this paper
• Complete nucleotide sequence of full length cDNA for rat α cardiac myosin hea chain

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy.

  1987cited by this paper
• Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

  1987cited by this paper
• Hormonal regulation of myosin heavy chain and alpha-actin gene expression in cultured fetal rat heart myocytes.

  1987cited by this paper
• Hypertrophic cardiomyopathy.

  1987cited by this paper
• Manipulating the mouse embryo: A laboratory manual

  1986cited by this paper
• Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy.

  1986cited by this paper
• α‐Skeletal Muscle Actin mRNA's Accumulate in Hypertrophied Adult Rat Hearts

  1986cited by this paper
• Cardiomyopathies and specific heart muscle diseases: definition, terminology and classification

  1985cited by this paper
• Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage.

  1984cited by this paper
• Myocardial disarray. A critical review.

  1982cited by this paper
• Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy.

  1979cited by this paper
• Voluntary muscle involvement in hypertrophic cardiomyopathy. A study of eleven patients.

  1976cited by this paper
• The purification of cardiac myofibrils with Triton X-100.

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Cleavage of structural proteins during

  1970cited by this paper

• Hypertrophic Cardiomyopathy-Associated CRYABR123W Activates Calcineurin, Reduces Calcium Sequestration, and Alters the CRYAB Interactome and the Proteomic Response to Pathological Hypertrophy

  2025cites this paper
• Experimental Models of Hypertrophic Cardiomyopathy

  2025cites this paper
• Allele-specific dysregulation of lipid and energy metabolism in early-stage hypertrophic cardiomyopathy

  2024influential citation
• Effects of a Global Rab27a Null Mutation on Murine PVAT and Cardiovascular Function

  2024cites this paper
• Single-nucleus RNA/ATAC-seq in early-stage HCM models predicts SWI/SNF-activation in mutant-myocytes, and allele-specific differences in fibroblasts

  2024cites this paper
• Incomplete-penetrant hypertrophic cardiomyopathy MYH7 G256E mutation causes hypercontractility and elevated mitochondrial respiration

  2024cites this paper
• Hearts apart: sex differences in cardiac remodeling in health and disease

  2024cites this paper
• Ungated, plug‐and‐play preclinical cardiac CEST‐MRI using radial FLASH with segmented saturation

  2024cites this paper
• Multi-scale models reveal hypertrophic cardiomyopathy MYH7 G256E mutation drives hypercontractility and elevated mitochondrial respiration

  2023cites this paper
• A novel αB-crystallin R123W variant drives hypertrophic cardiomyopathy by promoting maladaptive calcium-dependent signal transduction

  2023cites this paper
• Lipid metabolism drives allele-specific early-stage hypertrophic cardiomyopathy

  2023cites this paper
• Experimental Model of Cardiotoxicity

  2022cites this paper
• Animal Models to Study Cardiac Arrhythmias

  2022cites this paper
• Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy

  2022cites this paper
• Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy

  2022cites this paper
• Electrophysiological and Structural Remodeling of the Atria in a Mouse Model of Troponin-I Mutation Linked Hypertrophic Cardiomyopathy: Implications for Atrial Fibrillation

  2021cites this paper
• Small Vessel Disease: Another Component of the Hypertrophic Cardiomyopathy Phenotype Not Necessarily Associated with Fibrosis

  2021cites this paper
• Transgenic rabbit models for cardiac disease research

  2021cites this paper
• Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy

  2021cites this paper
• Using 4-vinylcyclohexene diepoxide as a model of menopause for cardiovascular disease.

  2020cites this paper
• Altered Tyrosine Phosphorylation of Cardiac Proteins Prompts Contractile Dysfunction in Hypertrophic Cardiomyopathy

  2020cites this paper
• MYBPC3 Haplotype Linked to Hypertrophic Cardiomyopathy in Rhesus Macaques (Macaca mulatta).

  2020cites this paper
• Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy

  2019cites this paper
• Phenotypic variation and targeted therapy of hypertrophic cardiomyopathy using genetic animal models.

  2019cites this paper
• Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy

  2019cites this paper
• INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY.

  2019cites this paper
• Put “gender glasses” on the effects of phenolic compounds on cardiovascular function and diseases

  2018cites this paper
• Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy

  2018cites this paper
• Molecular and Cellular Mechanisms in Heart Failure

  2018cites this paper
• Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models.

  2018cites this paper
• Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs

  2018cites this paper
• Dilated cardiomyopathy myosin mutants have reduced force-generating capacity

  2018cites this paper
• The Female Athlete’s Heart: Facts and Fallacies

  2018cites this paper
• A One Health Approach to Hypertrophic Cardiomyopathy

  2017cites this paper
• Inherited Cardiomyopathies: From Genotype to Phenotype

  2017cites this paper
• Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy

  2016cites this paper
• Cardiac remodelling in hypertrophic cardiomyopathy and diabesity

  2016cites this paper
• Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.

  2016cites this paper
• Sex-dependent pathophysiological mechanisms in hypertrophic cardiomyopathy: implications for rhythm disorders.

  2015cites this paper
• The impact of biological sex on crossbridge cycling kinetics in mice expressing the R403Q mutation

  2015cites this paper
• Diet and sex modify exercise and cardiac adaptation in the mouse.

  2015cites this paper
• Estrogen Dependent Regulation of the Amp-Activated Protein Kinase Pathway

  2015influential citation
• dietthe cardiac transcriptional landscape with

  2015cites this paper
• The genetic landscape of cardiomyopathy and its role in heart failure.

  2015cites this paper
• Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period.

  2015cites this paper
• Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy

  2014cites this paper
• Age-related changes in familial hypertrophic cardiomyopathy phenotype in transgenic mice and humans

  2014cites this paper
• Hypertrophic Cardiomyopathy: How do Mutations Lead to Disease?

  2014cites this paper
• Mouse models of heart failure: cell signaling and cell survival.

  2014cites this paper
• Severe hypertrophic cardiomyopathy and heart failure caused by multiple mutations: from molecular pathogenesis to pharmacological intervention

  2013cites this paper
• Temporal and morphological impact of pressure overload in transgenic FHC mice

  2013cites this paper
• Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice.

  2013cites this paper
• The Genetics of Cardiac Electrophysiology in Humans

  2013cites this paper
• Rabbit Genetics and Transgenic Models

  2012cites this paper
• Lost in Transgenesis: A User's Guide for Genetically Manipulating the Mouse in Cardiac Research

  2012cites this paper
• Micro-RNA-195 and -451 Regulate the LKB1/AMPK Signaling Axis by Targeting MO25

  2012cites this paper
• Transgenic rabbit models for studying human cardiovascular diseases.

  2012cites this paper
• Transgenic Rabbit Models for Atherosclerosis

  2012cites this paper
• Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease.

  2012cites this paper
• Remodeling the cardiac transcriptional landscape with diet.

  2011cites this paper
• protein C mutation carriers with hypertrophic cardiomyopathy Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding

  2011cites this paper
• Cellular mechanisms of cardiomyopathy

  2011cites this paper
• The role of MEKK1 in hypertrophic cardiomyopathy.

  2010cites this paper
• What We Know and Do Not Know about Sex and Cardiac Disease

  2010influential citation
• Animal Models of Heart Failure

  2010cites this paper
• Sex-based cardiac physiology.

  2009cites this paper
• Cardiomyopathy and Heart Failure in Aging

  2008cites this paper
• Severe Heart Failure and Early Mortality in a Double-Mutation Mouse Model of Familial Hypertrophic Cardiomyopathy

  2008cites this paper
• A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular non-compaction in humans, results in left ventricular hypertrophy that progresses to dilation in a mouse model.

  2008cites this paper
• Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.

  2007cites this paper
• Déterminants génétiques du contrôle de la masse cardiaque et/ou de la taille des cardiomyocytes dans des croisements expérimentaux de rongeurs

  2007cites this paper
• The effects of biological sex and diet on the development of heart failure.

  2007cites this paper
• Exercise Can Prevent and Reverse the Severity of Hypertrophic Cardiomyopathy

  2006cites this paper
• GENES, CALCIUM AND MODIFYING FACTORS IN HYPERTROPHIC CARDIOMYOPATHY

  2006cites this paper
• Diversity in transcriptional start site selection and alternative splicing affects the 5′-UTR of mouse striated muscle myosin transcripts

  2006cites this paper
• Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms.

  2006cites this paper
• THE ROLE OF THE PROTEIN PHOSPHATASE 1 INHIBITOR-1 IN REGULATION OF MURINE CARDIAC PHYSIOLOGY AND PROGRESSION OF CARDIOMYOPATHY

  2006cites this paper
• Review of dilated cardiomyopathies. Dilated cardiomyopathies and altered prothrombotic state: a point of view of the literature.

  2005cites this paper
• Inherited Myocardial Diseases

  2005cites this paper
• Soy diet worsens heart disease in mice.

  2005cites this paper
• Taking a bite out of hypertrophic cardiomyopathy: soy diet and disease.

  2005cites this paper
• Male Sex Aggravates the Phenotype in Mouse Models of Hypertrophic Cardiomyopathy

  2005cites this paper
• Loaded wheel running and muscle adaptation in the mouse.

  2005cites this paper
• The Critical Role of Phospholamban in Cardiac Function

  2004cites this paper
• Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing

  2004cites this paper
• Gender modulates cardiac phenotype development in genetically modified mice.

  2004cites this paper
• Sex differences in cardiac muscle and remodeling

  2004cites this paper
• Morphological and Functional Alterations in Ventricular Myocytes From Male Transgenic Mice With Hypertrophic Cardiomyopathy

  2004cites this paper
• Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A.

  2004cites this paper
• Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy.

  2003cites this paper
• Expression systems to analyze transgenes in the heart

  2003cites this paper
• Yin Yang 1 Is Increased in Human Heart Failure and Represses the Activity of the Human α-Myosin Heavy Chain Promoter*

  2003cites this paper
• The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.

  2002cites this paper
• From sarcomeric mutations to heart disease: understanding familial hypertrophic cardiomyopathy.

  2002cites this paper
• Genética molecular de las miocardiopatías

  2002cites this paper
• Coronary artery myogenic response in a genetic model of hypertrophic cardiomyopathy.

  2002cites this paper
• Molecular diagnosis of myocardial disease

  2002cites this paper
• Cardiomyopathies and Myofibril Abnormalities

  2002cites this paper
• On Koch's postulates, causality and genetics of cardiomyopathies.

  2002cites this paper
• Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice.

  2002cites this paper